Cti Biopharma Corp. 

WA

  SEC # 891293

        

Click to view...

Registrant

About

Filings

Files

Relationships

Names

Topics

Web

Registrant
 SEC-Registered:  9/9/92   —   First EDGAR Filing:  6/27/96   –   Last Filing:  7/6/23 

Possible Termination of Registration and/or Duty to File Reports per 7/6/23 Form 15

Business Address      On:  7/6/23       [ Map ]		Mailing Address      On:  7/6/23       [ Map ]
3101 Western Avenue Suite 800 Seattle, Washington  98121 U.S.A.

Phone #		Organized In		Fiscal-Year End		IRS #		SEC CIK		SEC File #
+1 206-282-7100		Delaware, U.S.A.		12/31/yy		91-1533912		0000891293		000-28386

Industry Classification
GICS – Global Industry Classification Standard:        Sector      →    Sub-Industry   Health Care Biotechnology   ICB – Industry Classification Benchmark:               Industry    →       Subsector      Health Care Biotechnology   SIC:     Code      U.S. Industry      Through      Source      Filings-Review Office 2834 Pharmaceutical Preparations 2023 SEC Office of Life Sciences

        

Management
Director   In   MN   Tuckson Reed Vaughn 2011-2023   CA   Perry Matthew D 2016-2023   NY   Craig Adam R 2017-2023   CA   Fischer Laurent 2017-2023   MA   Metzger Michael A 2017-2023   CA   Parkinson David Ross 2017-2023   CA   BVF Partners LP/IL 2021-2023   NJ   Parks Diane L. 2021-2023   CA   Biotechnology Value Fund II LP 2022-2023   CA   Biotechnology Value Fund LP 2022-2023   Biotechnology Value Trading Fund OS LP 2022-2023   CA   BVF GP Holdings LLC 2022-2023   CA   BVF I GP LLC 2022-2023   CA   BVF II GP LLC 2022-2023   CA   BVF Inc./IL 2022-2023   BVF Partners OS Ltd. 2022-2023   CA   Lampert Mark N 2022-2023 ↓List Pre-2019 Directors				Officer  Since  Most-Recent Title   In   WA   Fong James K 2022 EVP & Chief Commercial Officer 2023   NY   Craig Adam R 2017 President & CEO 2023   WA   Kirske David 2017 EVP, Chief Financial Officer 2023   WA   Seeley Bruce J. 2015 EVP, Chief Operating Officer 2022 ↓List Pre-2019 Officers

        

        

        

        

Securities
Market:  Symbol       (Prices)   Nasdaq:  CTIC   _________  Symbol source:  SEC  As of:  6/30/23 – Old		CUSIP, CINS or PPN       Description ← Symbol   Issuer Issue (Class or re: Filing — Name)      To 2024:   12648L 12648L·10·6     Common 12648L·01·5     Options 12648L·60·1     Common — COM NPV ← CTIC _________  Classes source:  Form 13F Filings that list Section 13(f) Securities